GDRX 📈 Goodrx Holdings - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US38246G1085
GDRX: Prescription, Prices, Comparison, Subscriptions, Telehealth, Pharmacy
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. Web URL: https://www.goodrx.com
Additional Sources for GDRX Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GDRX Stock Overview
Market Cap in USD | 1,871m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 2020-09-23 |
GDRX Stock Ratings
Growth 5y | -75.3% |
Fundamental | 42.5% |
Dividend | - |
Rel. Strength Industry | -672 |
Analysts | 3.81/5 |
Fair Price Momentum | 3.18 USD |
Fair Price DCF | 21.94 USD |
GDRX Dividends
No Dividends PaidGDRX Growth Ratios
Growth Correlation 3m | -84.5% |
Growth Correlation 12m | -7.3% |
Growth Correlation 5y | -68.4% |
CAGR 5y | -43.50% |
CAGR/Mean DD 5y | -0.63 |
Sharpe Ratio 12m | -0.36 |
Alpha | -71.83 |
Beta | 1.70 |
Volatility | 59.25% |
Current Volume | 3245.9k |
Average Volume 20d | 1238.4k |
What is the price of GDRX stocks?
As of December 22, 2024, the stock is trading at USD 4.44 with a total of 3,245,889 shares traded.
Over the past week, the price has changed by -5.73%, over one month by +3.02%, over three months by -35.75% and over the past year by -29.41%.
As of December 22, 2024, the stock is trading at USD 4.44 with a total of 3,245,889 shares traded.
Over the past week, the price has changed by -5.73%, over one month by +3.02%, over three months by -35.75% and over the past year by -29.41%.
Is Goodrx Holdings a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Goodrx Holdings (NASDAQ:GDRX) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.54 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GDRX as of December 2024 is 3.18. This means that GDRX is currently overvalued and has a potential downside of -28.38%.
Partly, yes. Based on ValueRay Fundamental Analyses, Goodrx Holdings (NASDAQ:GDRX) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.54 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GDRX as of December 2024 is 3.18. This means that GDRX is currently overvalued and has a potential downside of -28.38%.
Is GDRX a buy, sell or hold?
Goodrx Holdings has received a consensus analysts rating of 3.81. Therefor, it is recommend to buy GDRX.
Goodrx Holdings has received a consensus analysts rating of 3.81. Therefor, it is recommend to buy GDRX.
- Strong Buy: 6
- Buy: 2
- Hold: 7
- Sell: 1
- Strong Sell: 0
What are the forecast for GDRX stock price target?
According to ValueRays Forecast Model, GDRX Goodrx Holdings will be worth about 3.5 in December 2025. The stock is currently trading at 4.44. This means that the stock has a potential downside of -20.72%.
According to ValueRays Forecast Model, GDRX Goodrx Holdings will be worth about 3.5 in December 2025. The stock is currently trading at 4.44. This means that the stock has a potential downside of -20.72%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7 | 58.3% |
Analysts Target Price | 8.7 | 96.6% |
ValueRay Target Price | 3.5 | -20.7% |